Institut Mérieux
Institut Mérieux is a French holding company owned by the Mérieux family from Lyon.
History[edit]
It was created by Marcel Mérieux in 1897 under the name Institut Biologique Mérieux (Mérieux Biological Institute). The vaccine development branch of the institute was separated early on and is now part of Sanofi Pasteur.[1],[2],[3] The current name was changed in 2009 from Mérieux Alliance.[1] The holding is owned through the Mérieux Alliance company at 68% by Alain and Alexandre Mérieux and at 32% by the Christophe and Rodolphe Mérieux foundation (different from the Mérieux foundation).[4]
Alongside diagnostic activities, Alain Mérieux develops new complementary bio-industrial activities. The holding company then took in 1994, the control of Transgene, specialized in gene therapy, then of Silliker (specialized in food security),[5] in 1998. In 2001, Biomérieux acquired the diagnostic company Organon Teknika. Its Advanced Bioscience Laboratories Inc. sector, a contract research company, is then bought by the Mérieux family holding company.[6]
In 2010, the institute structured its nutrition and health division around Silliker and Biofortis under the name of Mérieux NutriSciences.[7]
In January 2020, Institut Mérieux co-founded the Hub VPH, the first global hub in veterinary public health, whose objective is to catalyze the driving forces of research, innovation, education and industry in the Auvergne-Rhône-Alpes region around this activity.[8]
Holding[edit]
Through creations and acquisitions, the holding is managing the following companies:[1],[4],[9]
- BioMérieux, created by Alain Mérieux in 1963, owned at 59%
- Mérieux NutriSciences, renamed from the acquired Chicago-based company Silliker, and encompassing the Biofortis and Bioagri companies,[10] owned at 70% by the holding
- Transgene "designs and develops therapeutic vaccines and immunotherapy products to treat cancers and infectious diseases" and is owned at 55% by the holding[11]
- Advanced BioScience Laboratories, Inc, an unlisted company dedicated to research and development of infectious diseases, AIDS in particular; owned entirely by the holding[12]
- Mérieux Développement
- IMAccess, a not for profit company dedicated to the development, production and supply of rapid diagnostic tests to developing countries, owned entirely by the holding[13]
References[edit]
- ^ a b c "A shared vision - History". Institut Mérieux. Archived from the original on 5 May 2012. Retrieved 16 May 2014.
- ^ "Histoire de Sanofi" (PDF) (in French). Archived (PDF) from the original on 17 May 2014. Retrieved 17 May 2014.
- ^ "Timeline of Institut Mérieux". Institut Mérieux. Archived from the original (JPG) on 17 May 2014. Retrieved 16 May 2014.
- ^ a b "Organization chart". Mérieux Institute. Retrieved 17 May 2014.
- ^ "Chronologie de l'institut Mérieux". institut-merieux.com. Institut Mérieux. Archived from the original on 17 May 2014. Retrieved 17 May 2014..
- ^ "La saga Mérieux en 15 dates clés". www.leprogres.fr (in French). Retrieved 2021-04-20.
- ^ "La saga Mérieux en 15 dates clés". www.leprogres.fr (in French). Retrieved 2022-07-22.
- ^ "Santé publique vétérinaire : comment Lyon veut s'imposer dans l'écosystème mondial". La Tribune (in French). 2020-01-30. Retrieved 2022-07-22.
- ^ "Institut Mérieux An International Presence". Retrieved 16 May 2014.
- ^ "History of Mérieux NutriSciences". Retrieved 16 May 2014.
- ^ "Transgene company". Mérieux Institute. Retrieved 16 May 2014.
- ^ "ABL, Inc society". Mérieux Institute. Retrieved 16 May 2014.
- ^ "IMAccess company". Mérieux Institute. Retrieved 16 May 2014.
External links[edit]
- History page on the Fondation Mérieux website
| International | |
|---|---|
| National | |
| Other | |
